View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial...

Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates Launch of OLPRUVA® underway Topline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH symptoms Q4 2023 net revenue of $13.2M, and FY 2023 net revenue of $27.5M Conference call scheduled for today, March 28, 2024, at 4:30 p.m. ET  CELEBRATION, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today provided corporate updates and reported its financial resu...

 PRESS RELEASE

Probe Gold nomme Shannon McCrae à son conseil d’administration

Probe Gold nomme Shannon McCrae à son conseil d’administration TORONTO, 28 mars 2024 (GLOBE NEWSWIRE) -- PROBE GOLD INC. (TSX : PRB) (OTCQB : PROBF) (« Probe » ou la « Société ») annonce avec grand plaisir la nomination de Shannon McCrae à son conseil d’administration, prenant effet immédiatement. Mme Shannon McCrae est une géologue professionnelle et une dirigeante chevronnée qui cumule plus de 25 ans d’expérience dans l’industrie des ressources. Son expertise s’étend de l’exploration préliminaire aux sites miniers pour de multiples substances, ayant mené à d’importantes découvertes éco...

 PRESS RELEASE

Probe Gold Appoints Shannon McCrae to its Board of Directors

Probe Gold Appoints Shannon McCrae to its Board of Directors TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- PROBE GOLD INC. (TSX: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is very pleased to announce the appointment of Shannon McCrae to its board of directors, effective immediately. Ms. Shannon McCrae is a seasoned professional geologist and executive with more than 25 years of experience in the resource industry. Her expertise spans from early-stage exploration to mine sites across multiple commodities, leading to significant economic discoveries and innovative advancements. Recently,...

 PRESS RELEASE

Nokia Oyj: Omien osakkeiden takaisinosto 28.03.2024

Nokia Oyj: Omien osakkeiden takaisinosto 28.03.2024 Nokia OyjPörssitiedote28.03.2024 klo 22.30 Nokia Oyj: Omien osakkeiden takaisinosto 28.03.2024 Espoo – Nokia Oyj (LEI: 549300A0JPRWG1KI7U06) on 28.03.2024 hankkinut omia osakkeitaan (ISIN FI0009000681) omistukseensa seuraavasti: Markkinapaikka (MIC Code)Osakkeiden lukumääräPainotettu keskihinta osakkeelta, euroa*XHEL467 1243,29CEUX--BATE--AQEU--TQEX--Yhteensä467 1243,29 * Kahden desimaalin tarkkuuteen pyöristettynä Nokia ilmoitti 25. tammikuuta 2024, että yhtiön hallitus on käynnistämässä osakkeidensa takaisinosto-ohjelman palauttaaksee...

 PRESS RELEASE

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date f...

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for govorestat (AT-007) for the treatment of Classic Galactosemia by three months...

 PRESS RELEASE

Nokia Corporation: Repurchase of own shares on 28.03.2024

Nokia Corporation: Repurchase of own shares on 28.03.2024 Nokia CorporationStock Exchange Release28 March 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 28.03.2024 Espoo, Finland – On 28 March 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL467,1243.29CEUX--BATE--AQEU--TQEX--Total467,1243.29 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up...

 PRESS RELEASE

Apogee Minerals Announces Amendment to Option Agreement for the Pine C...

Apogee Minerals Announces Amendment to Option Agreement for the Pine Channel Property Vancouver, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) has amended the option agreement (the “Amendment Agreement”) with Eagle Plains (the “Optionor”) whereby the Optionor granted the Company the right to acquire up to an 80% interest in the Pine Channel Property (the “Property”). Under the amended terms of the Amendment Agreement, Apogee has been granted an extension on the due date of the CAD $50,000 cash pa...

 PRESS RELEASE

Puma Exploration Closes $625,000 Charity Flow-Through Private Placemen...

Puma Exploration Closes $625,000 Charity Flow-Through Private Placement RIMOUSKI, Québec, March 28, 2024 (GLOBE NEWSWIRE) -- Puma Exploration Inc. (TSX-V: PUMA, OTCQB: PUMXF) (the “Company” or “Puma”) announces that it has closed a non-brokered placement (the “CFT Private Placement”) consisting of 5,000,000 Charity flow-through units (the “CFT Units”) at $0.125 per CFT Unit for gross proceeds of C$625,000. Each CFT Unit is comprised of one Charity flow-through share and one-half (1/2) common share purchase warrant. Each whole warrant is exercisable to purchase one common share of the Comp...

 PRESS RELEASE

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 563...

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology’s Compensation Committee of the Board of Directors granted restricted stock units with respect to an aggregate of 39,680 shares of Pyxis Oncology’s common stock and stock options to purchase an aggregate of 49,600 shares of Pyxis Oncology’s common stock to a newly hired employee. The awa...

 PRESS RELEASE

Shapeways Reports Fourth Quarter and Full Year 2023 Results

Shapeways Reports Fourth Quarter and Full Year 2023 Results - Expands Q4 2023 Gross Margins to 46% and Increases Gross Profit by 23% vs the same quarter in the prior year -- Continues to Explore Strategic Alternatives to Maximize Shareholder Value - NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Shapeways Holdings, Inc. (NASDAQ: SHPW) (“Shapeways” or the “Company”), a leader in the large and fast-growing digital manufacturing industry, announced its results for the fourth quarter and year ended December 31, 2023. “Throughout 2023 we focused on executing our key strategic objectives of exp...

 PRESS RELEASE

Par Pacific Announces Expected Term Loan Repricing

Par Pacific Announces Expected Term Loan Repricing HOUSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Par Pacific Holdings, Inc. (NYSE: PARR) (“Par Pacific”) today announced it expects to reprice and allocate its existing term loan credit agreement due 2030 (the “Term Loan Facility”). The repricing amendment, which is subject to execution of definitive documentation and customary closing conditions, will reduce the Applicable Margin under the Term Loan Facility by 50 basis points, such that Base Rate loans and SOFR loans will bear interest at the applicable base rate plus 2.75% and 3.75%, respec...

 PRESS RELEASE

Maui Land & Pineapple Company Reports Fiscal 2023 Results

Maui Land & Pineapple Company Reports Fiscal 2023 Results KAPALUA, Hawaii, March 28, 2024 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the year ended December 31, 2023 and the date and time of their Annual Meeting of Stockholders, which will be held virtually on Wednesday, May 15, 2024, at 10:00 a.m., Hawai‘i Standard Time, via conference call. “After more than a century in operation and a multi-year focus on financial stabilization, Maui Land and Pineapple Company entered 2024 debt-free, with a new leadership team and a re...

 PRESS RELEASE

Centessa Pharmaceuticals Reports Business Highlights and Financial Res...

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023 Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist Program: Clinical proof-of-concept data for ORX750 in sleep-deprived healthy volunteers planned in 2024LockBody® Technology Platform: Ongoing Phase 1/2a study of LB101 (PD-L1xCD47) for the treatment of solid tumors BOSTON and LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Centessa Pha...

 PRESS RELEASE

Springbig Launches '20 Days of 4/20' Campaign to Empower Cannabis Disp...

Springbig Launches '20 Days of 4/20' Campaign to Empower Cannabis Dispensaries with Customer Retention Strategies The campaign strives to offer daily insights and recommendations for dispensaries to maximize the business impact of 4/20. BOCA RATON, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Springbig, a leading provider of vertical SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs, is thrilled to announce its latest initiative, the "20 Days of 4/20" campaign. This comprehensive campaign is positioned to enhance customer engagement strategies...

Moody's affirms Ingevity's ratings (CFR at Ba2), changes outlook to ne...

Moody's Ratings ("Moody's") has affirmed Ingevity Corporation's ("Ingevity's") Ba2 corporate family rating ("CFR"), Probability of Default Rating ("PDR") of Ba2-PD and the Ba3 rating on its senior unsecured notes. Ingevity's speculative grade liquidity rating remains at SGL-2, but the outlook was ch...

American Electric Power Company, Inc.: Update to credit analysis

Our credit view of AEP reflects its large and diversified asset base offset by high capex programs and inconsistent regulatory outcomes in some of its jurisdictions.

 PRESS RELEASE

NaaS Technology Inc. Reports Unaudited 2023 Fourth Quarter and Full Ye...

NaaS Technology Inc. Reports Unaudited 2023 Fourth Quarter and Full Year Financial Results BEIJING, March 28, 2024 (GLOBE NEWSWIRE) -- NaaS Technology Inc. (“NaaS” or the “Company”) (Nasdaq: NAAS), the first U.S. listed EV charging service company in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Financial Highlights: Revenues increased by 119% year over year and reached RMB64.4 million (US$9.1 million) for the fourth quarter of 2023. Revenues for the full year of 2023 were RMB320.1 m...

 PRESS RELEASE

Reed’s Reports Fourth Quarter and Full Year 2023 Results and Issues 20...

Reed’s Reports Fourth Quarter and Full Year 2023 Results and Issues 2024 Financial Outlook Sixth Consecutive Quarter of YoY Operating Expense and Profitability Improvements Execution of Optimization Initiatives Leads to Material Improvement in FY 2023 Operating Loss and Modified EBITDA NORWALK, Conn., March 28, 2024 (GLOBE NEWSWIRE) -- Reed’s, Inc. (OTCQX: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, is reporting financial results for the three and twelve months ended December 31, 2023. Q4 2023 Financial Highlight...

 PRESS RELEASE

Wintrust Financial Corporation Announces First Quarter 2024 Earnings R...

Wintrust Financial Corporation Announces First Quarter 2024 Earnings Release Schedule ROSEMONT, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ("Wintrust") (Nasdaq: WTFC) today announced it will release first quarter 2024 earnings results after the market closes on Wednesday, April 17, 2024 and host a conference call on Thursday, April 18, 2024 at 10:00 a.m. (CDT). For individuals wanting to listen to a simultaneous audio-only web cast, this may be accessed at . Individuals interested in participating in the call by addressing questions to management should regi...

 PRESS RELEASE

Eagle Bancorp, Inc. Announces Cash Dividend

Eagle Bancorp, Inc. Announces Cash Dividend BETHESDA, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the “Company”) (NASDAQ: EGBN), the parent company for EagleBank, today announced a cash dividend for the first quarter of 2024, in the amount of $0.45 per share. The cash dividend will be payable on April 30, 2024 to shareholders of record on April 18, 2024. About Eagle Bancorp: The Company is the holding company for EagleBank, which commenced operations in 1998. The Bank is headquartered in Bethesda, Maryland, and operates through thirteen branch offices, located in Suburba...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch